Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, and it spreads through respiratory droplets and close physical contact. Diphtheria Vaccine is a vaccine produced from diphtheria toxoid (a non-toxic form of the toxin) that against Corynebacterium diphtheriae.

The global Diphtheria Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Diphtheria Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diphtheria Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
Merck
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
DTaP Vaccines
Tdap Vaccines
Td Vaccines
DT Vaccines

Segment by Application
Adults
Children